Alexander Anisimov

Alexander Anisimov

Auto-generated profile, based on publicly available information

Alexander Anisimov

Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, 1478, Norway

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Autophagy
Verified
Journal Article
Closed access
Ruixue AiRuixue Ai
Ruixue Ai
XZXu-Xu Zhuang
Xu-Xu Zhuang
AAAlexander Anisimov
Alexander Anisimov
JLJiahong Lu
Jiahong Lu
EFEvandro Fang
Evandro Fang
Failed recognition and clearance of damaged mitochondria contributes to memory loss as well as Aβ and MAPT/Tau pathologies in Alzheimer disease (AD), for which there is an unmet therapeutic need. Restoring mitophagy to eliminate damaged mitochondria could abrogate metabolic dysfunction, neurodegeneration and may subsequently inhibit or slow down cognitive decline in AD models. We have developed a high-throughput machine-learning approach combined with a cross-species screening platform to discover novel mitophagy-inducing compounds from a natural product library and further experimentally validated the potential candidates. Two lead compounds, kaempferol and rhapontigenin, induce neuronal mitophagy and reduce Aβ and MAPT/Tau pathologies in a PINK1-dependent manner in both C. elegans and mouse models of AD. Our combinational approach provides a fast, cost-effective, and highly accurate method for identification of potent mitophagy inducers to maintain brain health.

29 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TSTomas Schmauck-Medina
Tomas Schmauck-Medina
AAAlexander Anisimov
Alexander Anisimov
DMDavid Meyer
David Meyer
YHYue Hu
Yue Hu
ZHZebo Huang
Zebo Huang
EFEvandro Fang
Evandro Fang
Enhancing autophagy increases lifespan and healthspan in animal models, yet the precise molecular mechanisms underlying these effects are not fully understood. Here we show that overexpression of the essential autophagic gene atg-18 extends the lifespan of C. elegans . We describe a previously unknown, pleiotropic mechanism by which atg-18 impacts lysosomes and extends lifespan through the transcription factor hlh-30 , the master regulator of lysosomal biogenesis. We show that, under stress conditions, HLH-30 requires atg-18 for nuclear translocation. Furthermore, atg-18 overexpression broadly improves health and stress resilience yet paradoxically increases early-life susceptibility to lethal heat stress. In contrast, enhances heat-stress survival a loss-of-function of function mutation in atg-18 enhances heat-stress survival, uncovering a temporal-specific effect of atg-18 . These finding suggest an ATG-18—HLH-30 autophagy—lysosome pathway that plays a key role in lifespan and healthspan. Bulleted main discoveries: ATG-18 overexpression increases C. elegans lifespan and plays an important role in resilience against starvation and heat stress. ATG-18 is required for nuclear translocation of HLH-30 HLH-30 is required for ATG-18—mediated lifespan extension ATG-18 positively regulates lysosomal biogenesis, suggesting a novel role as a molecular coordinator between autophagy and the lysosomal network.